JP2021520207A5 - - Google Patents

Info

Publication number
JP2021520207A5
JP2021520207A5 JP2020554254A JP2020554254A JP2021520207A5 JP 2021520207 A5 JP2021520207 A5 JP 2021520207A5 JP 2020554254 A JP2020554254 A JP 2020554254A JP 2020554254 A JP2020554254 A JP 2020554254A JP 2021520207 A5 JP2021520207 A5 JP 2021520207A5
Authority
JP
Japan
Application number
JP2020554254A
Other languages
Japanese (ja)
Other versions
JP7419252B2 (ja
JPWO2019193144A5 (https=
JP2021520207A (ja
Filing date
Publication date
Priority claimed from EP17165007.0A external-priority patent/EP3385380A1/en
Priority claimed from PCT/EP2018/058764 external-priority patent/WO2018185240A1/en
Priority claimed from EP18197795.0A external-priority patent/EP3550022A1/en
Priority claimed from PCT/EP2019/058615 external-priority patent/WO2019193144A1/en
Application filed filed Critical
Publication of JP2021520207A publication Critical patent/JP2021520207A/ja
Publication of JP2021520207A5 publication Critical patent/JP2021520207A5/ja
Publication of JPWO2019193144A5 publication Critical patent/JPWO2019193144A5/ja
Priority to JP2024001366A priority Critical patent/JP2024036347A/ja
Publication of JP7419252B2 publication Critical patent/JP7419252B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020554254A 2017-04-05 2019-04-05 アンチセンス鎖の5’末端でビニルホスホネートを有するsiRNA Active JP7419252B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024001366A JP2024036347A (ja) 2017-04-05 2024-01-09 アンチセンス鎖の5’末端でビニルホスホネートを有するsiRNA

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP17165007.0A EP3385380A1 (en) 2017-04-05 2017-04-05 Products and compositions
EP17201405 2017-11-13
PCT/EP2018/058764 WO2018185240A1 (en) 2017-04-05 2018-04-05 Products and compositions
EPPCT/EP2018/058764 2018-04-05
EP18197795.0 2018-09-28
EP18197795.0A EP3550022A1 (en) 2018-04-05 2018-09-28 Products and compositions
PCT/EP2019/058615 WO2019193144A1 (en) 2018-04-05 2019-04-05 siRNAs WITH VINYLPHOSPHONATE AT THE 5' END OF THE ANTISENSE STRAND

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001366A Division JP2024036347A (ja) 2017-04-05 2024-01-09 アンチセンス鎖の5’末端でビニルホスホネートを有するsiRNA

Publications (4)

Publication Number Publication Date
JP2021520207A JP2021520207A (ja) 2021-08-19
JPWO2019193144A5 JPWO2019193144A5 (https=) 2023-11-15
JP2021520207A5 true JP2021520207A5 (https=) 2023-11-15
JP7419252B2 JP7419252B2 (ja) 2024-01-22

Family

ID=61899310

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020504435A Active JP7247167B2 (ja) 2017-04-05 2018-04-05 産物及び組成物
JP2020554254A Active JP7419252B2 (ja) 2017-04-05 2019-04-05 アンチセンス鎖の5’末端でビニルホスホネートを有するsiRNA
JP2023039774A Active JP7495544B2 (ja) 2017-04-05 2023-03-14 産物及び組成物
JP2024001366A Pending JP2024036347A (ja) 2017-04-05 2024-01-09 アンチセンス鎖の5’末端でビニルホスホネートを有するsiRNA

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020504435A Active JP7247167B2 (ja) 2017-04-05 2018-04-05 産物及び組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023039774A Active JP7495544B2 (ja) 2017-04-05 2023-03-14 産物及び組成物
JP2024001366A Pending JP2024036347A (ja) 2017-04-05 2024-01-09 アンチセンス鎖の5’末端でビニルホスホネートを有するsiRNA

Country Status (18)

Country Link
US (2) US11174483B2 (https=)
EP (2) EP3607068B1 (https=)
JP (4) JP7247167B2 (https=)
KR (1) KR102589803B1 (https=)
CN (2) CN110573619B (https=)
AU (2) AU2018247924B2 (https=)
CA (2) CA3057561C (https=)
DK (1) DK3607068T3 (https=)
ES (1) ES2936109T3 (https=)
FI (1) FI3607068T3 (https=)
HR (1) HRP20221547T1 (https=)
HU (1) HUE061894T2 (https=)
IL (2) IL269576B2 (https=)
LT (1) LT3607068T (https=)
PL (1) PL3607068T3 (https=)
RS (1) RS63887B1 (https=)
SI (1) SI3607068T1 (https=)
WO (1) WO2018185240A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102365961B1 (ko) 2011-03-29 2022-02-23 알닐람 파마슈티칼스 인코포레이티드 Tmprss6 유전자의 발현을 억제하기 위한 조성물 및 방법
EP4029942A1 (en) 2017-04-05 2022-07-20 Silence Therapeutics GmbH Products and compositions
JP7155239B2 (ja) * 2017-04-05 2022-10-18 サイレンス・セラピューティクス・ゲーエムベーハー 産物及び組成物
EP3598995A1 (en) * 2018-07-26 2020-01-29 Silence Therapeutics GmbH Products and compositions
CN111973619B (zh) * 2019-05-23 2024-01-30 苏州瑞博生物技术股份有限公司 核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
US20240240187A1 (en) 2021-04-27 2024-07-18 Silence Therapeutics Gmbh Sirna targeting tmprss6 for the treatment of myeloproliferative disorders
TWI868755B (zh) 2022-06-24 2025-01-01 丹麥商諾佛 儂迪克股份有限公司 抑制跨膜絲胺酸蛋白酶6(tmprss6)表現的組成物及方法
WO2024060649A1 (zh) * 2022-09-29 2024-03-28 广州必贝特医药股份有限公司 用于抑制TMPRSS6基因表达的siRNA或其盐、药物及其应用
EP4687983A1 (en) 2023-03-27 2026-02-11 Silence Therapeutics GmbH Compounds and compositions for use in stem cell transplantation
WO2025132845A1 (en) 2023-12-21 2025-06-26 Silence Therapeutics Gmbh Galnac phosphoramidites and their uses
WO2025163186A1 (en) * 2024-02-01 2025-08-07 Silence Therapeutics Gmbh Conjugated nucleic acids and nucleic acids comprising locked nucleosides and inverted nucleotides for inhibiting gene expression in a cell
WO2026003163A1 (en) 2024-06-26 2026-01-02 Silence Therapeutics Gmbh Sirna against tmprss6 for treating polycythemia vera

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9201440A (nl) 1992-08-11 1994-03-01 Univ Leiden Triantennaire clusterglycosiden, hun bereiding en toepassing.
EP2305812A3 (en) * 2002-11-14 2012-06-06 Dharmacon, Inc. Fuctional and hyperfunctional sirna
KR101869570B1 (ko) * 2010-04-28 2018-06-20 아이오니스 파마수티컬즈, 인코포레이티드 변형된 뉴클레오사이드 및 그로부터 제조된 올리고머 화합물
KR102365961B1 (ko) * 2011-03-29 2022-02-23 알닐람 파마슈티칼스 인코포레이티드 Tmprss6 유전자의 발현을 억제하기 위한 조성물 및 방법
EP3650544A1 (en) * 2011-11-07 2020-05-13 Ionis Pharmaceuticals, Inc. Modulation of tmprss6 expression
KR102486617B1 (ko) 2013-05-22 2023-01-12 알닐람 파마슈티칼스 인코포레이티드 Tmprss6 조성물 및 이의 사용 방법
IL316808A (en) * 2014-08-20 2025-01-01 Alnylam Pharmaceuticals Inc Modified double-stranded RNA materials and their uses
WO2016055601A1 (en) * 2014-10-10 2016-04-14 F. Hoffmann-La Roche Ag Galnac phosphoramidites, nucleic acid conjugates thereof and their use
WO2016085852A1 (en) * 2014-11-24 2016-06-02 Alnylam Pharmaceuticals, Inc. Tmprss6 irna compositions and methods of use thereof
US20160272970A1 (en) * 2015-03-17 2016-09-22 Arrowhead Madison Inc. RNA Interference Agents
EP3228326A1 (en) 2016-04-05 2017-10-11 Silence Therapeutics GmbH Nucleic acid linked to a trivalent glycoconjugate
JP7155239B2 (ja) * 2017-04-05 2022-10-18 サイレンス・セラピューティクス・ゲーエムベーハー 産物及び組成物
EP4029942A1 (en) * 2017-04-05 2022-07-20 Silence Therapeutics GmbH Products and compositions

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
JP2021520207A5 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)